Manufacturer's investigation conclusion: a direct correlation between heartmate ii left ventricular assist system (hm3 lvas), serial number: (b)(6), and the reported events and patient outcome could not be conclusively established through this evaluation.It was reported by the account that the patient passed away on (b)(6) 2021 due to septic shock.Additional information received from the customer indicated that the patient went into respiratory arrest and had aspiration pneumonia.The patient had also presented with decreased hemoglobin and melena and gastrointestinal (gi) bleeding was confirmed via esophagogastroduodenoscopy (egd).The device was reported to have operated as expected and the death was not considered to be device related.The device will not be returned for evaluation.The relevant sections of the device history record for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate ii left ventricular assist system (hmii lvas) instructions for use (ifu) is currently available.Section 1, ("introduction") lists potential adverse events that may be associated with the use of the hm3 lvas, including death, sepsis, respiratory failure, and bleeding.Section 6, (¿patient care and management¿), provides information regarding anticoagulation, including the recommended international normalized ratio (inr) values.No further information provided.The manufacturer is closing the file on this event.
|